Nu-Med Plus (NUMD) 10-Q 11 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 07, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'Nu-Med Plus, Inc.	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Entity Central Index Key	'0001543637	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	32,756,346
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'

NuMed_Plus_Inc_A_Development_S

Nu-Med Plus, Inc. (A Development Stage Company) Balance Sheets (unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current assets	'	'
Cash	$39,371	$13,229
Prepaid expenses, current	451,820	17,995
Total current assets	491,191	31,224
Long-term assets	'	'
Property and equipment, net	39,779	43,242
Prepaid expenses, long-term	12,559	21,556
Total long-term assets	52,338	64,798
Total assets	543,529	96,022
Current liabilities	'	'
Accounts payable	250	116
Accrued Expense	28,752	20,862
Convertible Promissory Note, Due on demand	230,100	199,384
Total current liabilities	259,102	220,362
Stockholders' equity (deficit)	'	'
Preferred stock; $0.001 par value per share; 10,000,000 authorized; no shares issued and outstanding, respectively.	0	0
Common stock; $0.001 par value per share; 90,000,000 authorized; 32,606,345 and 29,972,346 shares issued and outstanding, as of June 30, 2014 and December 31, 2013 respectively.	32,606	29,972
Additional paid-in capital	1,198,888	404,063
Stock subscription payable	67,500	40,300
Deficit accumulated during the development stage	-1,014,567	-598,675
Total stockholders' equity (deficit)	284,427	-124,340
Total liabilities and stockholders' equity (deficit)	$543,529	$96,022

NuMed_Plus_Inc_Balance_Sheet_P

Nu-Med Plus, Inc. Balance Sheet (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Statement of Financial Position	'	'
Preferred stock authorized	10,000,000	10,000,000
Preferred stock par value	$0.00	$0.00
Preferred stock issued	0	0
Preferred stock outstanding	0	0
Common stock authorized	90,000,000	90,000,000
Common stock par value	$0.00	$0.00
Common stock issued	32,606,345	29,972,346
Common stock outstanding	32,606,345	29,972,346

NuMed_Plus_Inc_A_Development_S1

Nu-Med Plus, Inc. (A Development Stage Company) Statements of Operations (unaudited) (USD $)	3 Months Ended		6 Months Ended		32 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Income Statement	'	'	'	'	'
Revenue	$0	$0	$0	$0	$0
Operating expenses	'	'	'	'	'
General and administrative expense	17,185	6,976	35,984	12,222	70,201
Payroll expense	15,142	12,154	30,273	23,789	141,461
Rent expense	4,164	4,164	8,328	8,328	39,476
Professional/Consulting Fees	160,079	9,914	299,240	68,685	613,162
Depreciation expense	1,732	699	3,464	1,398	8,494
Total operating expenses	198,302	33,907	377,289	114,422	872,794
Operating Loss	-198,302	-33,907	-377,289	-114,422	-872,794
Other income/expense	'	'	'	'	'
Interest income	0	0	2	0	21
Interest expense	-3,966	-2,768	-38,605	-4,910	-141,794
Total other income/expense	-3,966	-2,768	-38,603	-4,910	-141,773
Income tax expense	0	0	0	0	0
Net loss	($202,268)	($36,675)	($415,892)	($119,332)	($1,014,567)
Basic and diluted loss per share	($0.01)	$0	($0.01)	$0	'
Weighted average common shares outstanding - basic and diluted	32,273,104	26,804,012	32,009,571	26,804,012	'

NuMed_Plus_Inc_A_Development_S2

Nu-Med Plus, Inc. (A Development Stage Company) Statements of Cash Flows (unaudited) (USD $)	6 Months Ended		32 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Cash flows from operating activities:	'	'	'
Net loss	($415,892)	($119,332)	($1,014,567)
Depreciation	3,464	1,398	8,494
Stock for service	280,172	0	403,529
Services rendered for subscription receivable	0	0	13,000
Services contributed by officers	7,259	519	13,791
Amortization of the Beneficial Conversion Feature	30,716	0	115,050
Decrease in prepaid expenses	0	46,730	100,000
Increase in accounts payable	134	-3,075	250
Increase in accrued expense	7,890	4,680	29,252
Net cash used in operating activities	-86,257	-69,080	-331,201
Cash flows from investing activities:	'	'	'
Purchases of property and equipment	0	0	-48,273
Net cash used in investing activities	0	0	-48,273
Cash flows from financing activities	'	'	'
Proceeds from common stock	112,399	0	238,745
Proceeds from loan payable	0	76,600	182,008
Payments on loan payable	0	0	-1,908
Net cash provided by financing activities	112,399	76,600	418,845
Net increase/(decrease) in cash	26,142	7,520	39,371
Cash at beginning of period	13,229	731	0
Cash at end of period	39,371	8,251	39,371
Supplemental schedule of cash flow information	'	'	'
Cash paid for interest	0	0	0
Cash paid for income taxes	$0	$0	$0

Supplemental_Schedule_of_Nonca

Supplemental Schedule of Non-cash Financing Activities	6 Months Ended
	Jun. 30, 2014
Notes	'
Supplemental Schedule of Non-cash Financing Activities:	'
	Supplemental Schedule of Non-cash Financing Activities:
	For the six months ended June 30, 2014:
	The Company issued 2,350,000 shares of common stock for current and future services provided by consultants.
	The Company also issued 283,999 common shares valued at $0.30 per share for a total value of $85,200 in exchange for a $85,200 stock subscription payable.

Organization_and_Description_o

Organization and Description of Business	6 Months Ended
	Jun. 30, 2014
Notes	'
Organization and Description of Business	'
	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS
	Nu-Med Plus, Inc. is an emerging growth early stage medical device company principally engaged in the design, innovation, development, enhancement and commercialization of beginning, early, and selective later-stage quality medical devices. The Company's immediate focus is on a Nitric Oxide powder formulation that is 99% pure-with one year shelf life, a "clinical" generator device with controls plus safety monitors built in that delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a compact mobile rechargeable device to deliver inhaled Nitric Oxide gas. The Company is incorporated in Utah.
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	a. Accounting Method
	The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments which are necessary for a fair statement of the results for interim periods have been included.
	b. Revenue Recognition
	The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.
	c. Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
	d. Cash and Cash Equivalents
	The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.
	e. Fixed Assets
	Fixed assets are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the fixed assets are depreciated are five to seven years.
	f. Earnings per Share
	The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:
		For the Six Months ended June 30, 2014	For the Six Months ended June 30, 2013
	Net loss (numerator)	$                (415,892)	$                (119,332)
	Shares (denominator)	32,009,571	26,804,012
	Net loss per share amount	$                       (0.01)	$                       (0.00)
	Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. During the year there were no outstanding common stock equivalents. Furthermore, due to the net loss for the year, common stock equivalents would not be included in the calculation of the net loss per common share, as their inclusion would be anti-dilutive.
	g. Income Taxes
	Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	h. Equity Instruments Issued for Non-Cash Items
	In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.
	NOTE 3 - GOING CONCERN
	The Company anticipates that the funds on hand as of June 30, 2014, will not be sufficient and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $220,000 for 2014.  In April 2014, the Company entered into stock subscription agreements with two investors for them to purchase up to $165,000 of common stock at a price of $0.30 per share.  As such, the Company is funded through November 2014 and are in negotiations with  other investors to take the Company through 2014. Management will adjust any salaries and expenditures based on the need for successful continuous operations. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Fixed_Assets

Fixed Assets	6 Months Ended
	Jun. 30, 2014
Notes	'
Fixed Assets	'
	NOTE 4 - FIXED ASSETS
	Fixed assets and related accumulated depreciation consisted of the following at June 30, 2014, and December 31, 2013:
		30-Jun-14	31-Dec-13
	Equipment	$         48,273	$         48,273
	Accumulated depreciation	-8,494	-5,031
	Total Fixed Assets	$       39,779	$       43,242
	Depreciation expense for the six months ended June 30, 2014 and 2013, was $3,464 and $1,398, respectively.

Preferred_and_Common_Stock

Preferred and Common Stock	6 Months Ended
	Jun. 30, 2014
Notes	'
Preferred and Common Stock	'
	NOTE 5 - PREFERRED STOCK
	On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at June 30, 2014.
	NOTE 6 - COMMON STOCK
	In November and December of 2013, the Company received $40,300 for a Stock Subscription Payable.  In January and February of 2014, the Company received $38,400 for a Stock Subscription Payable.  The Stock Subscription Payable was relieved in February 2014 by the issuance of 262,333 shares of common stock at a value of $0.30 per share.
	On January 7, 2014, the Company issued 1,800,000 common shares valued at $0.30 per share for a total value of $ 540,000 to a consultant, as compensation, for current and future services to be provided from the date of issuance through January 7, 2015.
	In April of 2014, the Company received $6,500 for a Stock Subscription Payable. The Stock Subscription Payable was relieved in May 2014 by the issuance of 21,666 shares of common stock at a value of $0.30 per share.
	In April of 2014, the Company entered into a stock subscription agreement with two investors for them to purchase up to $165,000 of common stock at a price of $0.30 per share. In April, May and June of 2014, the Company received $67,500 for that Stock Subscription Payable. The Stock Subscription Payable is scheduled, by contract, to be relieved no later than October 1, 2014, by the issuance of 550,000 shares of common stock at a value of $0.30 per share.
	On May 23, 2014, the Company issued 350,000 common shares valued at $0.30 per share for a total value of $105,000 to a consultant, as compensation, for future services to be provided from June 1, 2014 through June 1, 2015.
	On May 24, 2014, the Company issued 200,000 common shares valued at $0.30 per share for a total value of $60,000 to a consultant, as compensation, for future services to be provided from June 1, 2014 through June 1, 2015.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2014
Notes	'
Commitments and Contingencies	'
	NOTE 7 - COMMITMENTS AND CONTINGENCIES
	Operating Lease Obligations
	The Company leases office space for which it incurred lease payments, on a month to month basis, beginning in February of 2012 for $1,000 per month. The Company also had a one year lease on lab space beginning April 1, 2012 and ending March 31, 2013, with a monthly lease payment of $388.  Pursuant to the lease agreement, at the end of one year, the term is month to month at the same rate of $388 per month.

Related_Party_Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2014
Notes	'
Related Party Transactions	'
	NOTE 8 - RELATED PARTY TRANSACTIONS
	Contributed Services
	During the six months ended June 30, 2014 and 2013, Company Officers contributed services to the Company in the amount of $7,259 and $ 519, respectively.  The Company officers received no compensation and have no expectation of compensation for these services, either now or in the future, and waive their rights to any such compensation.
	Compensation of Officers
	In October of 2011, 13,000,000 shares of common stock were issued to the Company's three founding members.  The issuance resulted in the recognition of a $13,000 stock subscription receivable as of December 31, 2011. On June 30, 2012, the $13,000 stock subscription was relieved, in full, in exchange for 2012 compensation paid to these founding members.
	Additionally, for 2012 the Company agreed to compensate its Chief Executive Officer $3,600 per month.  Beginning in January 2013 the Company agreed to compensate its CEO $3,550 per month.

Loan_Payable

Loan Payable	6 Months Ended
	Jun. 30, 2014
Notes	'
Loan Payable	'
	NOTE 9 - LOAN PAYABLE
	The Company received proceeds from a loan in the amount of $1,700 during 2011. This loan was due upon demand, had no stated interest rate, and was retired, in full, by payment in the second quarter of 2012. No interest was paid or recognized, during the year, due to the immateriality of such interest.
	The Company received, during the year ended December 31, 2013, additional proceeds from a loan in the amount of $91,600. The Lender has agreed to loan the Company up to $10,000 per month effective September 2012, for up to one year.  This loan was memorialized in writing on September 30, 2013. The loan is considered to be a demand note, with a maturity 30 days from the receipt of demand and the holder may not make demand for payment until six months from the date thereof. On June 30, 2014, the Company accrued additional interest on this note, at a rate of 8.0% in the amount of $5,161 for six months. The total loan balance and accrued interest is $130,100 and $13,482 respectively. The note contains a conversion option. The conversion price is one share for each $0.01 of principal and accrued but unpaid interest of the note subject to a beneficial ownership limitation. That limitation prevents the holder from owning more than 4.9% of the number of shares of the common stock outstanding after conversion. If the holder's ownership has not previously been reduced to less than 4.9% of the number of shares outstanding, then the limitation shall be 9.9%.
	On September 4, 2013 the Company entered into an agreement with a shareholder wherein shareholder would provide financing to the Company for two months at $25,000 per month. The note is due six months from the date it is presented and surrendered to the Company and bears an interest rate of 8.0% per annum. In September and October 2013, the Company received two $25,000 loans for a total of $50,000, and on October 28, 2013, the outstanding balance of $50,000 along with accrued interest of $500 was converted into common stock at a value of $0.30 per share.
	On November 14, 2012, the Company issued a $100,000 convertible promissory note to a consultant as compensation for services provided and to be provided during the period April, 1, 2012, through March 31, 2013. This note is due on demand, bears annual interest at 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion.  On September 27, 2013, the Company amended the note to include the conversion price which is one share for each $0.01 of principle and accrued but unpaid interest of the note. Of the original $100,000, $75,000 had been expensed as part of the professional/consulting fees on the statement of operations during the year ended December 31, 2012, and the remaining $25,000 was expensed ratably using the straight-line method over the last three months in the service period.  On June 30, 2014, the Company has accrued additional interest on this note in the amount of $2,727. for the six months ended June 30, 2014.  As of June 30, 2014, the company accrued interest on this note in the total amount of $12,356.
	The Company has evaluated these convertible under the provisions of ASC Topic 815 and has concluded that neither of the convertible contains an embedded derivative requiring bifurcation from the host contract. Therefore, we have accounted for the conversion features of these instruments in accordance with ASC Topic 470. Accordingly, we have recognized the value of beneficial conversion features in these instruments as the difference between the conversion price and the fair value of the Company’s common stock on the date of the transaction.  As a result the Company has recognized debt discounts resulting from these beneficial conversion features amounting to $50,000 and $65,050, respectively, for the November 14, 2012 and September 27, 2013 notes.  The value of these discounts is to be accreted to the loans over the remaining contractual lives of the loans.  Accretion recognized as additional interest expense during the periods ended June 30, 2014 and December 31, 2013 was $30,716 and $84,334, respectively. The ending value of the debt discount as of June 30, 2014 and December 31, 2013 was $0 and $30,716, respectively.

Subsequent_Events

Subsequent Events	6 Months Ended
	Jun. 30, 2014
Notes	'
Subsequent Events	'
	NOTE 10 - SUBSEQUENT EVENTS
	The Company has evaluated subsequent events in accordance with ASC Topic 855 and has determined that there are no reportable subsequent events.

Organization_and_Description_o1

Organization and Description of Business (Policies)	6 Months Ended
	Jun. 30, 2014
Policies	'
Accounting Method	'
	a. Accounting Method
	The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments which are necessary for a fair statement of the results for interim periods have been included.
Revenue Recognition	'
	b. Revenue Recognition
	The Company is currently developing its products. It is anticipated that revenue will be recognized on product sales once the product has been shipped to the customers, persuasive evidence of an agreement exists, the price is fixed or determinable, and collectability is reasonably assured.
Estimates	'
	c. Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
Cash and Cash Equivalents	'
	d. Cash and Cash Equivalents
	The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents.
Fixed Assets	'
	e. Fixed Assets
	Fixed assets are stated at cost.  Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized.  Depreciation is computed using the straight-line method.  The lives over which the fixed assets are depreciated are five to seven years.
Earnings Per Share	'
	f. Earnings per Share
	The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement as follows:
		For the Six Months ended June 30, 2014	For the Six Months ended June 30, 2013
	Net loss (numerator)	$                (415,892)	$                (119,332)
	Shares (denominator)	32,009,571	26,804,012
	Net loss per share amount	$                       (0.01)	$                       (0.00)
	Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. During the year there were no outstanding common stock equivalents. Furthermore, due to the net loss for the year, common stock equivalents would not be included in the calculation of the net loss per common share, as their inclusion would be anti-dilutive.
Income Taxes	'
	g. Income Taxes
	Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Equity Instruments Issued For Non-cash Items	'
	h. Equity Instruments Issued for Non-Cash Items
	In accordance with ASC Topic 718, the Company records equity instruments issued for non-cash items at the grant-date fair value of the equity instruments issued.
Going Concern	'
	NOTE 3 - GOING CONCERN
	The Company anticipates that the funds on hand as of June 30, 2014, will not be sufficient and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $220,000 for 2014.  In April 2014, the Company entered into stock subscription agreements with two investors for them to purchase up to $165,000 of common stock at a price of $0.30 per share.  As such, the Company is funded through November 2014 and are in negotiations with  other investors to take the Company through 2014. Management will adjust any salaries and expenditures based on the need for successful continuous operations. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Organization_and_Description_o2

Organization and Description of Business (Tables)	6 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Schedule of Earnings Per Share, Basic and Diluted	'
		For the Six Months ended June 30, 2014	For the Six Months ended June 30, 2013
	Net loss (numerator)	$                (415,892)	$                (119,332)
	Shares (denominator)	32,009,571	26,804,012
	Net loss per share amount	$                       (0.01)	$                       (0.00)

Fixed_Assets_Tables

Fixed Assets (Tables)	6 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Property, Plant and Equipment	'
		30-Jun-14	31-Dec-13
	Equipment	$         48,273	$         48,273
	Accumulated depreciation	-8,494	-5,031
	Total Fixed Assets	$       39,779	$       43,242

Organization_and_Description_o3

Organization and Description of Business (Details) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended		32 Months Ended
	Apr. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Details	'	'	'	'	'	'
Net loss	'	($202,268)	($36,675)	($415,892)	($119,332)	($1,014,567)
Weighted average common shares outstanding - basic and diluted	'	32,273,104	26,804,012	32,009,571	26,804,012	'
Basic and diluted loss per share	'	($0.01)	$0	($0.01)	$0	'
Planned expenditures	'	'	'	$220,000	'	'
Stock Issued During Period, Shares, Issued for Services	165,000	'	'	'	'	'
Price per share of shares issued for services	'	'	'	$0.30	'	'

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	6 Months Ended		32 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Dec. 31, 2013
Details	'	'	'	'
Property, Plant and Equipment, Gross	$48,273	'	$48,273	$48,273
Accumulated Depreciation	-8,494	'	-8,494	-5,031
Property and equipment, net	39,779	'	39,779	43,242
Depreciation	$3,464	$1,398	$8,494	'

Preferred_and_Common_Stock_Det

Preferred and Common Stock (Details) (USD $)	1 Months Ended		2 Months Ended	3 Months Ended	6 Months Ended		32 Months Ended
	31-May-14	Apr. 30, 2014	Feb. 28, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	24-May-14	23-May-14	Dec. 31, 2013
Details	'	'	'	'	'	'	'	'	'	'
Preferred stock authorized	'	'	'	10,000,000	10,000,000	'	10,000,000	'	'	10,000,000
Preferred stock par value	'	'	'	$0.00	$0.00	'	$0.00	'	'	$0.00
Stock subscription payable	'	$6,500	'	$67,500	$67,500	'	$67,500	'	'	$40,300
Proceeds from common stock	'	'	38,400	'	112,399	0	238,745	'	'	'
shares issued for stock subscription	'	'	'	'	262,333	'	'	'	'	'
Sale of Stock, Price Per Share	'	'	'	$0.30	$0.30	'	$0.30	'	'	'
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures	'	'	'	'	1,800,000	'	'	'	'	'
total value of shares issued for compensation	'	'	'	540,000	540,000	'	540,000	'	'	'
Stock subscription shares	21,666	'	'	550,000	'	'	'	'	'	'
Stock Issued During Period, Shares, Issued for Services	'	165,000	'	'	'	'	'	'	'	'
share based compensation shares	'	'	'	'	'	'	'	200,000	350,000	'
share based compensation value	'	'	'	'	'	'	'	$60,000	$105,000	'

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	6 Months Ended
	Jun. 30, 2014
Details	'
monthly office lease payment	$1,000
monthly lab lease payment	$388

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	3 Months Ended	6 Months Ended		12 Months Ended		32 Months Ended
	Dec. 31, 2011	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2012	Dec. 31, 2011	Jun. 30, 2014
Details	'	'	'	'	'	'
Services contributed by officers	'	$7,259	$519	'	'	$13,791
Stock Issued During Period, Shares, New Issues	13,000,000	'	'	'	'	'
StockSubscriptionReceivableRelieved	'	'	'	'	13,000	'
Officers' Compensation	'	$3,550	'	$3,600	'	'

Loan_Payable_Details

Loan Payable (Details) (USD $)	6 Months Ended		12 Months Ended		32 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2014	Dec. 31, 2011
Details	'	'	'	'	'	'
Loans Payable, Current	'	'	'	'	'	$1,700
Additional Loan Proceeds	91,600	'	'	'	91,600	'
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current	'The Lender has agreed to loan the Company up to $10,000 per month effective September 2012, for up to one year	'	'	'	'	'
Accounts Payable, Interest-bearing, Interest Rate	8.00%	'	'	'	8.00%	'
additional loan accrued interest	5,161	'	'	'	'	'
Convertible Notes Payable	130,100	'	'	'	130,100	'
convertible note payable accrued interest	13,482	'	'	'	'	'
Debt Instrument, Convertible, Terms of Conversion Feature	'The conversion price is one share for each $0.01 of principal and accrued but unpaid interest of the note subject to a beneficial ownership limitation. That limitation prevents the holder from owning more than 4.9% of the number of shares of the common stock outstanding after conversion. If the holder's ownership has not previously been reduced to less than 4.9% of the number of shares outstanding, then the limitation shall be 9.9%.	'	'	'	'	'
Shareholder Loan Amount Per Month	25,000	'	'	'	25,000	'
Related Party Transaction, Amounts of Transaction	50,000	'	'	'	'	'
Debt Conversion, Original Debt, Amount	50,000	'	'	'	50,000	'
Debt Conversion Accrued Interest	500	'	'	'	'	'
Debt Instrument, Convertible, Conversion Price	0.3	'	'	'	0.3	'
November convertible promissory note	100,000	'	'	'	100,000	'
Debt Conversion, Original Debt, Interest Rate of Debt	5.50%	'	'	'	'	'
Price per share	$0.01	'	'	'	'	'
Decrease in prepaid expenses	0	46,730	'	75,000	100,000	'
Consulting fee balance expensed	25,000	'	'	'	25,000	'
Additional Convertible Promissory Note Accrued Interest	2,727	'	'	'	'	'
Debt Instrument, Convertible, Interest Expense	12,356	'	'	'	'	'
Debt Instrument, Convertible, Beneficial Conversion Feature	'	'	65,050	50,000	'	'
Amortization of the Beneficial Conversion Feature	30,716	0	84,334	'	115,050	'
The ending value of the debt discount	$0	'	$30,716	'	$0	'